Jiya Acquisition Corp. is a blank check company formed for the purpose of effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization or similar business combination with one or more businesses. While the Company may pursue an initial business combination target in any industry or geographic location, it intends to focus its search for a target business operating in the biotechnology and pharmaceuticals sector.
Company profile
Ticker
JYAC
Exchange
Website
Employees
Incorporated
Location
Fiscal year end
Industry (SIC)
SEC CIK
Corporate docs
IRS number
852789517
JYAC stock data
Latest filings (excl ownership)
15-12G
Securities registration termination
25 Nov 22
25-NSE
Exchange delisting
23 Nov 22
10-Q
2022 Q3
Quarterly report
22 Nov 22
8-K
Jiya Acquisition Corp. Announces Redemption of Class A Common Stock
18 Nov 22
NT 10-Q
Notice of late quarterly filing
14 Nov 22
8-K
Departure of Directors or Certain Officers
9 Sep 22
8-K
Jiya Acquisition Corp. Receives Nasdaq Notification of
2 Sep 22
10-Q
2022 Q2
Quarterly report
31 Aug 22
NT 10-Q
Notice of late quarterly filing
12 Aug 22
8-K
Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant
13 Jun 22
Latest ownership filings
SC 13G/A
ACUTA CAPITAL PARTNERS, LLC
14 Feb 23
SC 13G/A
CITADEL ADVISORS LLC
14 Feb 23
SC 13G/A
GLAZER CAPITAL, LLC
13 Feb 23
SC 13G/A
ARISTEIA CAPITAL LLC
10 Feb 23
4
SRINIVAS AKKARAJU
23 Sep 22
SC 13G
Saba Capital Management, L.P.
6 May 22
SC 13G/A
GLAZER CAPITAL, LLC
14 Feb 22
SC 13G/A
ARISTEIA CAPITAL LLC
14 Feb 22
SC 13G/A
CITADEL ADVISORS LLC
14 Feb 22
SC 13G
Sculptor Capital LP
28 Jan 22
Financial summary
Quarter (USD) | Sep 22 | Jun 22 | Mar 22 | Dec 21 | |
---|---|---|---|---|---|
Revenue | |||||
Cost of revenue | |||||
Operating income | |||||
Operating margin | |||||
Net income | |||||
Net profit margin | |||||
Cash on hand | |||||
Change in cash | |||||
Diluted EPS |
Annual (USD) | Dec 21 | Dec 20 | |
---|---|---|---|
Revenue | |||
Cost of revenue | |||
Operating income | |||
Operating margin | |||
Net income | |||
Net profit margin | |||
Cash on hand | |||
Change in cash | |||
Diluted EPS |
Cash burn rate (est.) | Burn method: Change in cash | Burn method: Operating income | Burn method: FCF (opex + capex) | Last Q | Avg 4Q | Last Q | Avg 4Q | Last Q | Avg 4Q |
---|---|---|---|---|---|---|
Cash on hand (at last report) | 102.45 k | 102.45 k | 102.45 k | 102.45 k | 102.45 k | |
Cash burn (monthly) | 44.43 k | 75.42 k | 193.70 k | 169.52 k | 31.60 k | |
Cash used (since last report) | 837.49 k | 1.42 mm | 3.65 mm | 3.20 mm | 595.67 k | |
Cash remaining | -735.03 k | -1.32 mm | -3.55 mm | -3.09 mm | -493.21 k | |
Runway (months of cash) | -16.5 | -17.5 | -18.3 | -18.2 | -15.6 |
Institutional ownership, Q3 2022
13F holders | Current |
---|---|
Total holders | 51 |
Opened positions | 5 |
Closed positions | 7 |
Increased positions | 7 |
Reduced positions | 8 |
13F shares | Current |
---|---|
Total value | 173.09 mm |
Total shares | 12.74 mm |
Total puts | 0.00 |
Total calls | 0.00 |
Total put/call ratio | – |
Largest owners | Shares | Value |
---|---|---|
Jiya Holding | 2.64 mm | $27.16 mm |
Saba Capital Management | 967.01 k | $9.64 mm |
Citadel Advisors | 683.46 k | $6.82 mm |
Sculptor Capital | 641.16 k | $6.39 mm |
Acuta Capital Partners | 562.50 k | $5.61 mm |
Aristeia Capital | 551.10 k | $5.50 mm |
Samsara BioCapital | 507.04 k | $5.06 mm |
EcoR1 Capital | 500.00 k | $4.99 mm |
Periscope Capital | 493.56 k | $4.92 mm |
Partner Fund Management | 464.10 k | $4.63 mm |